Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults (Discovery)
2. juli 2026 oppdatert av: Abdelaziz Alsharawy, The University of Texas Health Science Center, Houston
Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults
This study seeks to:
- Identify behavioral preference patterns that characterize older adults vulnerable to financial exploitation.
- Estimate the extent to which biases in decision-making process influence financial decisions among older adults vulnerable to financial exploitation to refine information content and behavioral 'nudge' strategies.
Studieoversikt
Status
Har ikke rekruttert ennå
Studietype
Observasjonsmessig
Registrering (Antatt)
400
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Abdelaziz Alsharawy, PhD
- Telefonnummer: (713) 500-9000
- E-post: Abdelaziz.Alsharawy@uth.tmc.edu
Studiesteder
-
-
Texas
-
Houston, Texas, Forente stater, 77030
- The University of Texas Health Science Center at Houston
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Ja
Prøvetakingsmetode
Ikke-sannsynlighetsprøve
Studiepopulasjon
For online-only participation, 200 older adults (OAs) recruited via Prolific, a crowdsourcing platform.
Those participating in-lab at the Health Decision Science Lab will include 200 OAs recruited from the Houston area (that is, participants who signed up to the study team's SONA system database).
Beskrivelse
Inclusion Criteria:
- Adults over the age of 60
- English speakers, to ensure comprehension of study tasks
Exclusion Criteria:
- Less than age 60
- Non-English speaker
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Older Adults who are less vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
|
Older Adults who are more vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Frequency of choosing the riskier option on the risk tolerance decision-making task
Tidsramme: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize risk tolerance (willingness to accept uncertain outcomes).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more trusting option on the trust decision-making task
Tidsramme: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize interpersonal trust (willingness to accept being vulnerable to other people).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more altruistic option on the altruism decision-making task
Tidsramme: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize altruism (willingness to incur a financial cost to benefit another person).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more patient option on the impatience decision-making task
Tidsramme: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize patience (willingness to forego a sooner reward for a bigger future reward).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the less loss-averse option on the loss-aversion decision-making task
Tidsramme: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize loss aversion (tendency to weigh potential losses more heavily than equivalent gains).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Physiological arousal as measured via heart rate
Tidsramme: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via skin conductance
Tidsramme: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via pupil dilation
Tidsramme: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Frequency of facial expressions associated with valence and engagement
Tidsramme: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Facial expressions will be assessed using a facial expression analysis system (iMotions software).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Attention as assessed by eye fixations
Tidsramme: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Relative fixation duration on each option in the behavioral tasks will be measured via an eye tracker (SmartEye).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Response time during the behavioral tasks
Tidsramme: During the time of the decision-making tasks (about 20-40 minutes)
|
Response time will be reported as the time from stimulus presentation to choice, in milliseconds.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Abdelaziz Alsharawy, PhD, The University of Texas Health Science Center, Houston
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. august 2026
Primær fullføring (Antatt)
1. desember 2027
Studiet fullført (Antatt)
1. desember 2027
Datoer for studieregistrering
Først innsendt
26. juni 2026
Først innsendt som oppfylte QC-kriteriene
26. juni 2026
Først lagt ut (Faktiske)
6. juli 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
7. juli 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
2. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- HSC-SPH-25-0344 (Discovery)
- P30AG086563 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .